Interferon alpha-2a in combination therapies for the treatment of chronic hepatitis C in prior non-responders to interferon monotherapy

被引：0
|
作者：
Salmeron, J
Diago, M
Andrade, R
Perez, R
Sola, R
Romero, M
De La Mata, M
Granados, R
Torrente, V
Aguilar, J
Planas, R
Perez-Moreno, J
Casanovas, T
机构：
[1] Univ Hosp, Liver Unit, Granada, Spain
[2] Gen Hosp, Liver Unit, Valencia, Spain
[3] Hosp V De La Victoria, Liver Unit, Malaga, Spain
[4] Hosp Cent De Asturias, Liver Unit, Oviedo, Spain
[5] Hosp del Mar, Liver Unit, Barcelona, Spain
[6] Nuestra Senora De Valme, Liver Unit, Seville, Spain
[7] Hosp Reina Sofia, Liver Unit, Cordoba, Spain
[8] Hosp Dr Legrin, Liver Unit, Las Palmas Gran Canaria, Spain
[9] Hosp San Joan, Liver Unit, Tarragona, Spain
[10] Hosp Virgen Del Rocio, Liver Unit, Seville, Spain
来源：
JOURNAL OF HEPATOLOGY | 2003年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
580
引用
收藏
页码：168 / 168
页数：1
相关论文
共 50 条
  • [31] Treatment outcomes of recurrent hepatitis C: pegylated interferon in non-responders
    Devine, RM
    Heffron, TG
    Stieber, AC
    Smallwood, GA
    PHARMACOTHERAPY, 2004, 24 (10): : 1466 - 1466
  • [32] Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy:: a meta-analysis of individual patient data
    Cammà, C
    Bruno, S
    Schepis, F
    Lo Iacono, O
    Andreone, P
    Gramenzi, AG
    Mangia, A
    Andriulli, A
    Puoti, M
    Spadaro, A
    Freni, M
    Di Marco, V
    Cino, L
    Saracco, G
    Chiesa, A
    Crosignani
    Caporaso, N
    Morisco, F
    Rumi, MG
    Craxì, A
    GUT, 2002, 51 (06) : 864 - 869
  • [33] Nanomedicines in the treatment of chronic hepatitis C - focus on pegylated interferon alpha-2a
    Thomas, Thea
    Foster, Graham
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2007, 2 (01): : 19 - 24
  • [34] Treatment of chronic hepatitis C infection with interferon alpha-2a in a Turkish population
    Simsek, H
    Tatar, G
    Savas, C
    Telatar, H
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1996, 24 (01) : 132 - 137
  • [35] The response to interferon plus ribavirin re-treatment for chronic hepatitis C in interferon non-responders is not influenced by race
    De Maria, N
    Colantoni, A
    Idilman, R
    Harig, J
    Van Thiel, DH
    JOURNAL OF HEPATOLOGY, 2000, 33 (06) : 1028 - 1029
  • [36] Pegylated Interferon Alpha-2a and Ribavirin in the Treatment of Children with Chronic Hepatitis C
    Pawlowska, Malgorzata
    Halota, Waldemar
    GASTROENTEROLOGY, 2009, 136 (05) : A839 - A839
  • [37] A Comparison of Interferon alpha-2a Plus Ribavirin Combination Therapy with Peginterferon alpha-2a Plus Ribavirin Combination Therapy for the Treatment of Chronic Hepatitis C
    Demiraslan, Hayati
    Aygen, Bilgehan
    Yildiz, Orhan
    Soyuer, Isin
    Gokahmetoglu, Selma
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2008, 13 (01): : 12 - 22
  • [38] Re-treatment of chronic hepatitis C with interferon alpha and ribavirin in non-responders to interferon alpha alone - Analysis of the own experience and systematic review of the literature
    Wedemeyer, H
    Jaeckel, E
    HEPATOLOGY, 1998, 28 (04) : 713A - 713A
  • [39] Amantadine/alpha-interferon combination therapy in HCV chronic hepatitis patients non responders to alpha interferon
    Hurtovà, M
    Liuti, A
    Francioso, S
    Ombres, D
    Angelico, F
    JOURNAL OF HEPATOLOGY, 2000, 32 : 191 - 191
  • [40] Pre- and post-liver transplantation treatment for patients with hepatitis C: non-responders to interferon monotherapy
    Kwo, P
    NON-RESPONDING HEPATITIS C PATIENT: OPTIONS AND VARIABLES, 2000, (70): : 41 - 53
12345